AZTA News and Press, Azenta Inc. From 02/08/23

Azenta press release ( NASDAQ: AZTA ): Q1 Non-GAAP EPS of $0.12. Revenue of $178M (+27.1% Y/Y). Delivered Organic Growth Excluding COVID of 7% Reducing Cost Structure to Deliver Two Points of Margin Enhancement in 2 nd Half FY23 Guidance for Second Quarter Fisc...

Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022 PR Newswire Reported Q1'23 Revenue of $178 Million and Growth of 28% Year-Over-Year Delivered Organic Growth Excluding COVID of 7% Reducing Cost Structure to Deliver Two Points ...

Azenta Announces Fiscal 2023 First Quarter Earnings Conference Call and Webcast PR Newswire BURLINGTON, Mass. , Feb. 6, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2023 earnings which ended on December 31, 2022 on ...

Azenta ( NASDAQ: AZTA ) has acquired U.K.-based 2D barcode readers provider Ziath and its subsidiaries. The transaction is expected to be accretive to non-GAAP earnings in FY 2023 and GAAP earnings in FY 2024. Source: Press Release For further details see: Azent...

Azenta Announces the Acquisition of Ziath PR Newswire Enhances high-throughput workflow offerings with leading 2D barcode reader BURLINGTON, Mass. , Feb. 3, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has acquired Ziath, Ltd. ...

Summary RGA Investment Advisors, LLC is an independent investment management firm. The Company builds client portfolios with a low turnover, long-term investment strategy focused on identifying fundamentally attractive securities. Many businesses and investors alike, ourselves included,...

SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19, 2023. Dr. Nova succeeds Brian Birk,...

Summary Twist operates in a trendy space, with good growth, but atrocious margins. As profits are not in the company’s DNA, losses are likely to continue. Although the stock is down a lot, it still trades at a healthy valuation. The stock has limited downside protection i...

Azenta to participate in the 41st Annual J.P. Morgan Healthcare Conference PR Newswire BURLINGTON, Mass. , Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 41st Annual J.P. Morgan Healthcare ...

Azenta to participate in the 25th Annual Needham Growth Conference PR Newswire BURLINGTON, Mass. , Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 25th Annual Needham Growth Conference in ...